{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:26:34Z","timestamp":1781760394039,"version":"3.54.5"},"reference-count":20,"publisher":"Radiation Research Society","issue":"3","license":[{"start":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T00:00:00Z","timestamp":1530057600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bioone.org\/page\/resources\/researchers\/rights_and_permissions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiation Research"],"published-print":{"date-parts":[[2018,6,27]]},"DOI":"10.1667\/rr15048.1","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T17:53:24Z","timestamp":1530122004000},"page":"322","source":"Crossref","is-referenced-by-count":40,"title":["Complete Local and Abscopal Responses from a Combination of Radiation and Nivolumab in Refractory Hodgkin's Lymphoma"],"prefix":"10.1667","volume":"190","author":[{"given":"Qian","family":"Qin","sequence":"first","affiliation":[{"name":"epartment of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Nan","sequence":"additional","affiliation":[{"name":"epartment of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Fisher","sequence":"additional","affiliation":[{"name":"Department of Radiology, Houston Methodist Research Institute, Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Teh","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Houston Methodist Research Institute, Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Pandita","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, University of Toledo Medical Center, Toledo, Ohio, 43614"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Farach","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Houston Methodist Research Institute, Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Ravi","family":"Pingali","sequence":"additional","affiliation":[{"name":"epartment of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj K.","family":"Pandita","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Houston Methodist Research Institute, Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Brian","family":"Butler","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Houston Methodist Research Institute, Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tej K.","family":"Pandita","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Houston Methodist Research Institute, Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swaminathan P.","family":"Iyer","sequence":"additional","affiliation":[{"name":"epartment of"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1243","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"SL, Topalian, FS, Hodi, JR, Brahmer, et al. \"N Engl J Med.\" 366, \"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer\" 2443 (2012)","DOI":"10.1056\/NEJMoa1200690"},{"key":"2","doi-asserted-by":"crossref","unstructured":"MR, Green, S, Monti, SJ, Rodig, et al. \"Blood.\" 116, \"Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma\" 3268 (2010)","DOI":"10.1182\/blood-2010-05-282780"},{"key":"3","doi-asserted-by":"crossref","unstructured":"SM, Ansell, AM, Lesokhin, I, Borrello, et al. \"N Engl J Med.\" 372, \"PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma\" 311 (2015)","DOI":"10.1056\/NEJMoa1411087"},{"key":"4","doi-asserted-by":"crossref","unstructured":"P, Armand, MA, Shipp, V, Ribrag, et al. \"J Clin Oncol.\" 34, \"Programmed death-1 blockade with pembrolizumab in patients with classical Hodgkin lymphoma after brentuximab vedotin failure\" 3733 (2016)","DOI":"10.1200\/JCO.2016.67.3467"},{"key":"5","doi-asserted-by":"crossref","unstructured":"NA, Rizvi, MD, Hellmann, A, Snyder, et al. \"Science.\" 348, \"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer\" 124 (2015)","DOI":"10.1126\/science.aaa1348"},{"key":"6","doi-asserted-by":"crossref","unstructured":"RH. Mole, \"Br J Radiol.\" 26, \"Whole body irradiation; radiobiology or medicine?\" 234 (1953)","DOI":"10.1259\/0007-1285-26-305-234"},{"key":"7","doi-asserted-by":"crossref","unstructured":"BC, Burnette, H, Liang, Y, Lee, et al. \"Cancer Res.\" 71, \"The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity\" 2488 (2011)","DOI":"10.1158\/0008-5472.CAN-10-2820"},{"key":"8","doi-asserted-by":"crossref","unstructured":"K, Reynders, T, Illidge, S, Siva, et al. \"Cancer Treat Rev.\" 41, \"The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant\" 503 (2015)","DOI":"10.1016\/j.ctrv.2015.03.011"},{"key":"9","doi-asserted-by":"crossref","unstructured":"MA, Postow, MK, Callahan, CA, Barker, et al. \"N Engl J Med.\" 366, \"Immunologic correlates of the abscopal effect in a patient with melanoma\" 925 (2012)","DOI":"10.1056\/NEJMoa1112824"},{"key":"10","doi-asserted-by":"crossref","unstructured":"EF, Stamell, JD, Wolchok, S, Gnjatic, et al. \"Int J Radiat Oncol Biol Phys.\" 85, \"The abscopal effect associated with a systemic anti-melanoma immune response\" 293 (2013)","DOI":"10.1016\/j.ijrobp.2012.03.017"},{"key":"11","doi-asserted-by":"crossref","unstructured":"JR, Brahmer, SS, Tykodi, LQ, Chow, et al. \"N Engl J Med.\" 366, \"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer\" 2455 (2012)","DOI":"10.1056\/NEJMoa1200694"},{"key":"12","doi-asserted-by":"crossref","unstructured":"JM, Michot, R, Mazeron, L, Dercle, et al. \"Eur J Cancer.\" 66, \"Abscopal effect in a Hodgkin lymphoma patient treated by an anti-programmed death 1 antibody\" 91 (2016)","DOI":"10.1016\/j.ejca.2016.06.017"},{"key":"13","doi-asserted-by":"crossref","unstructured":"YD, Tseng, YH, Chen, PJ, Catalano, et al. \"Int J Radiat Oncol Biol Phys.\" 91, \"Rates and durability of response to salvage radiation therapy among patients with refractory or relapsed aggressive non-Hodgkin lymphoma\" 223 (2015)","DOI":"10.1016\/j.ijrobp.2014.09.041"},{"key":"14","doi-asserted-by":"crossref","unstructured":"TK. Pandita, \"Hum Genet.\" 63, \"Effect of temperature variation on sister chromatid exchange frequency in cultured human lymphocytes\" 189 (1983)","DOI":"10.1007\/BF00291543"},{"key":"15","doi-asserted-by":"crossref","unstructured":"RK, Pandita, GG, Sharma, A, Laszlo, et al. \"Mol Cell Biol.\" 26, \"Mammalian Rad9 plays a role in telomere stability, S- and G2-phase-specific cell survival, and homologous recombinational repair\" 1850 (2006)","DOI":"10.1128\/MCB.26.5.1850-1864.2006"},{"key":"16","doi-asserted-by":"crossref","unstructured":"TK, Pandita, S, Pathak, CR. Geard, \"Cytogenet Cell Genet.\" 71, \"Chromosome end associations, telomeres and telomerase activity in ataxia telangiectasia cells\" 86 (1995)","DOI":"10.1159\/000134069"},{"key":"17","doi-asserted-by":"crossref","unstructured":"TK, Pandita, HB, Lieberman, DS, Lim, et al. \"Oncogene.\" 19, \"Ionizing radiation activates the ATM kinase throughout the cell cycle\" 1386 (2000)","DOI":"10.1038\/sj.onc.1203444"},{"key":"18","doi-asserted-by":"crossref","unstructured":"C, Baues, R, Semrau, US, Gaipl, et al. \"Strahlenther Onkol.\" 193, \"Checkpoint inhibitors and radiation treatment in Hodgkin's lymphoma: New study concepts of the German Hodgkin Study Group\" 95 (2017)","DOI":"10.1007\/s00066-016-1050-4"},{"key":"19","doi-asserted-by":"crossref","unstructured":"C, Baues, M, Trommer-Nestler, K, Jablonska, et al. \"Immunotherapy.\" 9, \"Short review of potential synergies of immune checkpoint inhibition and radiotherapy with a focus on Hodgkin lymphoma: radio-immunotherapy opens new doors\" 423 (2017)","DOI":"10.2217\/imt-2017-0002"},{"key":"20","doi-asserted-by":"crossref","unstructured":"S, Demaria and SC. Formenti \"J Immunother Cancer.\" 4, \"Can abscopal effects of local radiotherapy be predicted by modeling T cell trafficking?\" 29 (2016)","DOI":"10.1186\/s40425-016-0133-1"}],"container-title":["Radiation Research"],"original-title":[],"link":[{"URL":"http:\/\/www.bioone.org\/doi\/full-xml\/10.1667\/RR15048.1","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T15:37:09Z","timestamp":1661528229000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/radiation-research\/volume-190\/issue-3\/RR15048.1\/Complete-Local-and-Abscopal-Responses-from-a-Combination-of-Radiation\/10.1667\/RR15048.1.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,27]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,9,1]]}},"URL":"https:\/\/doi.org\/10.1667\/rr15048.1","relation":{},"ISSN":["0033-7587"],"issn-type":[{"value":"0033-7587","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6,27]]}}}